RK

Rajeev Kumar Sharma

Active Director Director DIN 10400271
DIN 10400271 First appointment Nov 2023 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Rajeev Kumar Sharma

Data last updated:

Rajeev Kumar Sharma is a Director at Fee-Way Pharmaceuticals Private Limited (since 2023). The company operates in Chemicals. Fee-Way Pharmaceuticals Private Limited reported revenue of ₹2.9 Lakh (FY 2024).

DIN 10400271
Primary Designation Director
Industry Chemicals
First Appointment 09 Nov 2023
Oldest Company Age 5 yrs
Largest company Fee-Way Pharmaceuticals Private Limited · ₹2.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Nov 20232021₹2.9 Lakh (FY 2024)Active

Board colleagues of Rajeev Kumar Sharma

NameDINCompanyDesignation
Rohit Sharma09395706Fee-Way Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fee-Way Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajeev Kumar Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Kumar Sharma

Rajeev Kumar Sharma currently holds 1 directorship: Fee-Way Pharmaceuticals Private Limited (Director, since 09 Nov 2023, revenue ₹2.9 Lakh (FY 2024)).

Rajeev Kumar Sharma was first appointed on 09 Nov 2023 as Director at Fee-Way Pharmaceuticals Private Limited.

The current boards of Rajeev Kumar Sharma's companies include Rohit Sharma (Fee-Way Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available